cardiovascular-agents and Fetal-Death

cardiovascular-agents has been researched along with Fetal-Death* in 2 studies

Reviews

2 review(s) available for cardiovascular-agents and Fetal-Death

ArticleYear
Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association.
    Circulation, 2015, Nov-03, Volume: 132, Issue:18

    This is the first scientific statement from the American Heart Association on maternal resuscitation. This document will provide readers with up-to-date and comprehensive information, guidelines, and recommendations for all aspects of maternal resuscitation. Maternal resuscitation is an acute event that involves many subspecialties and allied health providers; this document will be relevant to all healthcare providers who are involved in resuscitation and specifically maternal resuscitation.

    Topics: Airway Management; Cardiopulmonary Resuscitation; Cardiovascular Agents; Critical Care; Early Medical Intervention; Electric Countershock; Emergency Medical Services; Female; Fetal Death; Heart Arrest; Humans; Hypotension; Hypoxia; Infant, Newborn; Oxygen Inhalation Therapy; Patient Positioning; Pregnancy; Pregnancy Complications, Cardiovascular

2015
Adverse effects of cardiovascular drug therapy on the fetus and neonate.
    Obstetrics and gynecology, 1981, Volume: 58, Issue:5 Suppl

    Possible adverse effects of cardiovascular medications on the fetus and the neonate have been reviewed. The major classes discussed were diuretics, antihypertensives, antiarrhythmics, cardiac glycosides, and anticoagulants. The recommendations given must not be considered definitive because they are based on flawed or incomplete information. It is to be hoped that further investigation will improve this situation and will also improve our understanding of the ways in which these drugs act.

    Topics: Abnormalities, Drug-Induced; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiac Glycosides; Cardiovascular Agents; Coumarins; Diuretics; Female; Fetal Death; Fetal Growth Retardation; Fetus; Heparin; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Cardiovascular

1981